BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36211403)

  • 1. CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression.
    Cocker ATH; Liu F; Djaoud Z; Guethlein LA; Parham P
    Front Immunol; 2022; 13():992723. PubMed ID: 36211403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.
    Jacobson A; Bell F; Lejarcegui N; Mitchell C; Frenkel L; Horton H
    PLoS One; 2013; 8(6):e67700. PubMed ID: 23805324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Dysfunctions of CD56
    Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
    Front Immunol; 2021; 12():811091. PubMed ID: 35069597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR- Ligand Interactions in Hypertensive Disorders in Pregnancy.
    Stefańska K; Tomaszewicz M; Dębska-Zielkowska J; Zamkowska D; Piekarska K; Sakowska J; Studziński M; Tymoniuk B; Adamski P; Jassem-Bobowicz J; Wydra P; Leszczyńska K; Świątkowska-Stodulska R; Kwiatkowski S; Preis K; Trzonkowski P; Marek-Trzonkowska N; Zieliński M
    Front Immunol; 2022; 13():868175. PubMed ID: 35911739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
    Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
    Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
    Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
    Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
    Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
    Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Characteristics of TIGIT-Expressing CD3
    Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
    Front Immunol; 2021; 12():602492. PubMed ID: 33717085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD56-CD16+ NK cell subset in chronic infections.
    Cocker ATH; Guethlein LA; Parham P
    Biochem Soc Trans; 2023 Jun; 51(3):1201-1212. PubMed ID: 37140380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated KIR expression and diminished intensity of CD7 on NK cell subsets among treatment naïve HIV infected Ethiopians.
    Andualem H; Lemma M; Keflie A; Workeneh M; Ayelign B; Tassachew Y; Hailu L; Geteneh A; Mihret A; Zewdie M; Howe R
    Sci Rep; 2022 Aug; 12(1):14747. PubMed ID: 36042218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis.
    Feng T; Liao X; Yang X; Yang C; Lin F; Guo Y; Kang Y; Li H
    J Leukoc Biol; 2020 Jan; 107(1):57-67. PubMed ID: 31385383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.